Sugar Trial: Amphilimus-Eluting Stents And Zotarolimus-Eluting Stents In Patients With Diabetes

SUGAR trial: Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

PCR

TCT 2021: SUGAR: Amphilimus-eluting Stents VS Zotarolimus-eluting Stents in Patients With DB

Radcliffe Cardiology

Amphilimus vs zotarolimus-eluting stent in patients with diabetes mellitus and CAD: the SUGAR trial

Journal Club Channel

AACE: Drug-Eluting Stent Performs Well in Diabetes Patients

MDedge: news and insights for busy physicians

Bare-Metal Stents versus Drug-Eluting Stents in Diabetics

Duke Clinical Research Institute

Monticello man receives new diabetic stent

Bare Metal and Drug-eluting Stents | What is the Difference?

Will the Abluminus stent have the ABILITY to treat patients with diabetes? - EuroPCR 2018

PCR

"Unveiling the Safety of Stents for Diabetic Patients: How Sugar Levels Impact Stents"

CARDIO AND HEART CARE ENGLISH

Abluminus DES+ - Designed to Treat Diabetic Patients- Sirolimus Eluting Coronary Stent

Concept Medical

ACC 2011_ NEXT-GENERATION ZOTAROLIMUS-ELUTING STENT EXHIBITS LOW RATE OF TARGET LESION FAILURE

Zotarolimus: Clinical Importance Medical Notes

Medicalsupernotes

Drug-Eluting Stent Symposium at TCT Connect 2020

Concept Medical

Flash Lecture: Revascularization in Diabetics: Back to the Drawing Board?

Empowering DES performance in complex patients to maximise efficacy and safety outcomes - #EuroPCR

PCR

Drug-Eluting Stent : Clinical Program Update - Dr Luca Testa : Abluminus DES+ : JIM 2021

Concept Medical

Apr 2022 - Randomized, Controlled Trial of Glucose-Sparing PD in Diabetic Patients

ISPD International Society for Peritoneal Dialysis

Cre8™ & DM patients: Turning challenges into today’s solution

Hope for improved PCI outcomes in diabetic patients with the Abluminus stent - EuroPCR 2019

PCR

Diabetes trials: challenges and current directions

European Society of Cardiology